Storage and handling
Store under normal storage conditions. Store away from children.
Store under normal storage conditions. Store away from children.
Active Ingredients (% by weight) Purpose Active Ingredients (% by weight) Purpose
Camphor 4.0% .........Anagelsic (pain relief) Menthol 4.0% ..........Anagelsic (pain relief)
For the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains, etc.
Warnings:
For external use only.KEEP OUT OF REACH OF CHILDREN.
Adults and children 12 years of age or older: Rub this soothing cream on the affected area not more than 3 to 4 times daily.
Children under the age of 12: Do not use, consult a doctor.
Store under normal storage conditions. Store away from children.
Questions? 416-967-3746 MADE IN CANADA
Manufactured for / ergo-health a division of Active and Innovative Inc.,| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49795-417-04 | 2025-11-14 | C162847 | 48780-1 | 956f9ecf-d0fb-621f-e053-dbdaa90a74ad | Professional Therapy MuscleCare Pain Relieving Cream |
| 49795-417-04 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d0fb-621f-e053-dbdaa90a74ad | Professional Therapy MuscleCare Pain Relieving Cream |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49795-417 | PROFESSIONAL THERAPY MUSCLE CARE PAIN RELIEVING OINTMENT BY DR. CHRIS OSWALD (CAMPHOR, MENTHOL) CREAM [NUTRI-DYN PRODUCTS LTD. DBA PROFESSIONAL HEALTH PRODUCTS] | 8 | Legacy NDC | 20100115_0e754371-1634-4120-a405-9998e6e63dbe.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Camphor | ACTIVE INGREDIENT | 5TJD82A1ET | 8 | |
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 8 | |
| Camphor | ACTIVE MOIETY | 5TJD82A1ET | 8 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 8 | |
| Cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 8 | |
| Dimethyl sulfone | INACTIVE INGREDIENT | 9H4PO4Z4FT | 8 | |
| Eucalyptus oil | INACTIVE INGREDIENT | 2R04ONI662 | 8 | |
| Glucosamine sulfate | INACTIVE INGREDIENT | 1FW7WLR731 | 8 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 8 | |
| Glycol stearate | INACTIVE INGREDIENT | 0324G66D0E | 8 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 8 | |
| Stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 8 | |
| Urea | INACTIVE INGREDIENT | 8W8T17847W | 8 | |
| Vitamin E | INACTIVE INGREDIENT | H4N855PNZ1 | 8 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49795-417 | 49795-417-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Camphor | 5TJD82A1ET | ACTIB |
| Menthol | L7T10EIP3A | ACTIB |
| Water | 059QF0KO0R | IACT |
| Cetyl alcohol | 936JST6JCN | IACT |
| Glycol stearate | 0324G66D0E | IACT |
| Dimethyl sulfone | 9H4PO4Z4FT | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Stearyl alcohol | 2KR89I4H1Y | IACT |
| Glucosamine sulfate | 1FW7WLR731 | IACT |
| Polysorbate 20 | 7T1F30V5YH | IACT |
| Urea | 8W8T17847W | IACT |
| Eucalyptus oil | 2R04ONI662 | IACT |
| Vitamin E | H4N855PNZ1 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Urea | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| Glycol stearate | GLYCOL STEARATE | 0324G66D0E | SHAMPOO, SUSPENSION / TOPICAL | 5 %w/w | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | TABLET / ORAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | CREAM / TOPICAL | 1280 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | SYSTEM / TOPICAL | 0.1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / TOPICAL | 3.7 %w/w | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUPPOSITORY / VAGINAL | 8.5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| Urea | UREA | 8W8T17847W | INSERT / VAGINAL | 50 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | OINTMENT / TOPICAL | 569 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | CAPSULE / ORAL | 16 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| Vitamin E | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.64 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAVENOUS | 30 mg | ||
| Urea | UREA | 8W8T17847W | TABLET, EFFERVESCENT / ORAL | 60 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, ORALLY DISINTEGRATING / ORAL | 9 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | CREAM / TOPICAL | 162000 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Urea | UREA | 8W8T17847W | DOUCHE / VAGINAL | 8 %w/w | ||
| Urea | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| Stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | LOTION / TOPICAL | 1140 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / ORAL | 80 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 436677d9-074f-3d4b-e063-6294a90a2b92 | 0e754371-1634-4120-a405-9998e6e63dbe | 2025-11-12 | Warnings | 0e754371-1634-4120-a405-9998e6e63dbe |
Adverse event summaries are temporarily unavailable. Other product information remains available.